Skip to content

LightForce EXPi LTS-2500Recalls & reported problems

Litecure LLC · Mains powered, infrared phototherapy and nail laser phototherapy device emitting up to 25 W at 980/810nm in CW or pulsed modes with a 10" touch screen display. · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00854103007059), received between Mar 20, 2019 and Mar 20, 2019 — classified as 1 injury.

The most frequently reported specific device problem is “Improper or Incorrect Procedure or Method” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Improper or Incorrect Procedure or Method1

Patient problems

  • Radiation Burn1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 20, 2019Improper or Incorrect Procedure or Method; Improper or Incorrect Procedure or Method

    PATIENT EXPERIENCED LESION ON SHOULDER SEVERAL DAYS AFTER TREATMENT DUE TO INCORRECT PROCEDURE BY OPERATOR. THE PROVIDED DOSE WAS GREATER THAN THE RECOMMENDED LEVEL LEADING TO OVEREXPOSURE. TREATMENT TECHNIQUE DID NOT FOLLOW IFU. ALSO, PATIENT HAD REDUCED SENSATION DUE TO EXISTING CONDITION THAT WAS NOT DISCLOSED PRIOR TO TREATMENT.

    Patient problems: Radiation Burn

    MAUDE report 8437526 ↗

Other Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis devices

All Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page